Related Experiment Video
Updated: Mar 14, 2026
Author Spotlight: Creating a Versatile Experimental Autoimmune Encephalomyelitis Model Relevant for Both Male and Female Mice
Published on: October 13, 2023
The association between prescribed hormonal contraception and multiple sclerosis risk: a systematic review and
Jessica McDonald1, Priya Sharma1, Christopher Tench1
1Mental Health and Clinical Neuroscience Unit, School of Medicine, University of Nottingham, Nottingham, UK.
Background:
Sex hormones can influence susceptibility to multiple sclerosis (MS). Around 400 million women worldwide use hormonal contraceptives (HC), which contain synthetic versions of female sex hormones. Evidence on HC use and MS risk is inconclusive. The aim of this study was to synthesise studies on the association between prescribed HC and the risk of MS.
Methods:
Medline, Embase, Cochrane library and grey literature were systematically searched on 7th November 2024. Two reviewers independently screened, extracted data and appraised each study's quality using the Joanna Briggs Institute critical appraisal tool. Pre-determined criteria were used to differentiate between high- and low-quality studies. Random-effects meta-analysis was conducted for studies providing the same effect measure; heterogeneity was assessed. Sensitivity analyses included only high-quality studies.
Results:
Eleven studies were included, six of these were cohort and five were case-control. Three studies were deemed high-quality. Five of the studies found no significant association between HC use and MS risk, four found a decreased risk, and two found an increased risk. Meta-analysis of the unadjusted odds ratio (OR) showed a significantly increased risk of MS with HC use of 1.28 (95% CI 1.08-1.52). However meta-analysis of adjusted ORs and sensitivity analyses showed no significant association. Heterogeneity was high.
Conclusion:
No statistically significant association between HC use and MS risk was observed. The meta-analyses indicate a possible increased risk warranting further investigation. Given that heterogeneity was high and only three of the included studies were classed as high-quality, a well-designed study is needed to clarify this association.
More Related Videos
10:46A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
Published on: December 9, 2015
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Related Concept Videos
01:22Birth Control Methods
01:22Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
01:22Hormonal Regulation of the Menstrual Cycle
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
01:24Disorders of the Female Reproductive System
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:30Hormonal Control of the Ovarian Cycle
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...